The World Market for Electronic Skin Patches, Forecast to 2029 - Abbott, Dexcom, Medtronic Dominate the $27 Billion Projected Market Landscape
May 23, 2024 09:25 ET
|
Research and Markets
Dublin, May 23, 2024 (GLOBE NEWSWIRE) -- The "Global Electronic Skin Patch Market by Type (Monitoring & Diagnostic, Therapeutic), Wireless Connectivity (Connected, Non-connected), Application...
Mitesco Announces Advisory Board Appointments
March 19, 2024 09:30 ET
|
Mitesco, Inc.
VERO BEACH, FL, March 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Mitesco, Inc. (OTC:MITI, “the Company”, www.mitescoinc.com ) today announced that it has appointed three (3) professionals to...
McEwen Mining: Stock Exploration Update
February 28, 2024 07:00 ET
|
McEwen Mining
Stock West and Stock Main gold resources increase by 31%, mineralization continuing at depth;Stock East emerging as a potential new source of near-term production. Assay highlights:Drillhole SEZ24-86:...
Global Enterprise WLAN Market to Surpass USD 102.96 billion by 2031 Driven by Increasing Demand for IoT Devices
February 19, 2024 08:38 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford USA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The introduction of WIFI6, a new wireless standard commonly referred to as 802.11ax, will have a beneficial market impact due to the continued...
NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today
February 06, 2024 08:00 ET
|
NightHawk Biosciences
DURHAM, N.C., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences / Scorpius Holdings, Inc. (NYSE American: NHWK; SCPX), an integrated contract development and manufacturing organization (CDMO),...
NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer
February 01, 2024 08:00 ET
|
NightHawk Biosciences
DURHAM, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) (“NightHawk” or the “Company”), an integrated contract development and manufacturing organization (CDMO),...
NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note
January 30, 2024 08:00 ET
|
NightHawk Biosciences
DURHAM, N.C., Jan. 30, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) (“NightHawk” or the “Company”), an integrated contract development and manufacturing organization (CDMO),...
NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program
January 25, 2024 08:30 ET
|
NightHawk Biosciences
DURHAM, N.C., Jan. 25, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) (“NightHawk” or the “Company”), an integrated contract development and manufacturing organization (CDMO),...
NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client
January 16, 2024 08:30 ET
|
NightHawk Biosciences
DURHAM, N.C., Jan. 16, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) (“NightHawk” or the “Company”), an integrated contract development and manufacturing organization (CDMO),...
NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO
January 08, 2024 08:30 ET
|
NightHawk Biosciences
DURHAM, N.C., Jan. 08, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK; NHWK), an integrated contract development and manufacturing organization (CDMO), today announced that it...